10.04.2013 Views

€5,000,000,000 Limited Recourse Secured Note Programme

€5,000,000,000 Limited Recourse Secured Note Programme

€5,000,000,000 Limited Recourse Secured Note Programme

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ISSUER ADDENDUM<br />

<strong>€5</strong>,<strong>000</strong>,<strong>000</strong>,<strong>000</strong><br />

<strong>Limited</strong> <strong>Recourse</strong> <strong>Secured</strong> <strong>Note</strong> <strong>Programme</strong><br />

Ashwell Rated S.A.<br />

(a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its<br />

registered office at Carré Bonn, 20, rue de la Poste, L-2346 Luxembourg and registered with the Luxembourg trade and companies<br />

register under number B. 107.848 and subject as an unregulated undertaking to the Luxembourg act dated 22 March 2004 on<br />

securitisation)<br />

This Issuer Addendum (the Issuer Addendum) in respect of Ashwell Rated S.A. (the Issuer or Ashwell<br />

Rated) has been prepared for the purpose of giving information about Ashwell Rated and incorporates by<br />

reference pages 1 to 194 (inclusive) of the base prospectus dated 22 November 2007 in relation to the<br />

<strong>€5</strong>,<strong>000</strong>,<strong>000</strong>,<strong>000</strong> <strong>Limited</strong> <strong>Recourse</strong> <strong>Secured</strong> <strong>Note</strong> <strong>Programme</strong> (the <strong>Programme</strong>) under which the Issuer issues<br />

<strong>Note</strong>s (the <strong>Note</strong>s) or, subject to restrictions of the Securitisation Act 2004, enters into loans (the Loans) from<br />

time to time, and comprises a base prospectus (the Base Prospectus) in respect of Ashwell Rated for the<br />

purposes of Article 5.4 of the Directive 2003/71/EC (the Prospectus Directive). This Issuer Addendum<br />

forms part of the Base Prospectus and incorporates by reference the rest of the Base Prospectus and all other<br />

documents which are deemed to be incorporated by reference in the Base Prospectus. The Issuer acceded to<br />

the <strong>Programme</strong> pursuant to a deed of adherence (the Deed of Adherence) dated 19 May 2005 between inter<br />

alia the Issuer and the Trustee. Unless the context otherwise requires, terms defined in the Base Prospectus<br />

shall have the same meaning when used in this Issuer Addendum.<br />

Application has been made to the Irish Financial Services Regulatory Authority, as competent authority<br />

under the Prospectus Directive 2003/71/EC, for the Base Prospectus to be approved. Such approval relates<br />

only to the <strong>Note</strong>s which are to be admitted to trading on the regulated market of the Irish Stock Exchange or<br />

other regulated markets for the purposes of Directive 2004/39/EC or which are to be offered to the public in<br />

any Member State or the European Economic Area. Application has been made to the Irish Stock Exchange<br />

for the <strong>Note</strong>s to be admitted to the Official List and trading on its regulated market.<br />

The Issuer accepts responsibility for the information contained in the Base Prospectus having taken all<br />

reasonable care to ensure that such is the case, the information contained in the Base Prospectus is, to the<br />

best of its knowledge, in accordance with the facts and does not omit anything likely to affect its import.<br />

The delivery of this Issuer Addendum at any time does not imply that any information contained herein is<br />

correct at any time subsequent to the date hereof.<br />

The information included in the applicable Series Prospectus with respect to the Charged Assets, the<br />

Reference Entity (or Reference Entities, as the case may be) and the Reference Obligations (in each case as<br />

applicable) will be accurately reproduced and as far as the Issuer is aware and is able to ascertain from the<br />

information published by any third party, no facts will have been omitted which would render the reproduced<br />

information inaccurate or misleading. No further or other responsibility in respect of such information is<br />

accepted by the Issuer.<br />

No person is or has been authorised by the Issuer to give any information or to make any representation not<br />

contained in or not consistent with this Issuer Addendum or any supplement or any other information<br />

supplied in connection with the <strong>Programme</strong> or the <strong>Note</strong>s and, if given or made, such information or<br />

representation must not be relied upon as having been authorised by the Issuer, the Trustee or Bear, Stearns<br />

International <strong>Limited</strong> as Arranger (the Arranger) or the relevant Dealer.<br />

1


Purchasers of <strong>Note</strong>s should conduct such independent investigation and analysis regarding the Issuer, the<br />

security arrangements (including, without limitation, with regard to any obligor of the Charged Assets, any<br />

Reference Entity, any Swap Counterparty, any Swap Guarantor, any Credit Support Provider and any Issuer<br />

Credit Enhancer and the full terms of the Charged Assets, Reference Obligations and the Charged<br />

Agreement(s) (in each case as applicable)) and the <strong>Note</strong>s as they deem appropriate to evaluate the merits and<br />

risks of an investment in the <strong>Note</strong>s. None of the Trustee, the Dealers or the Arranger have or will have<br />

separately verified the information contained herein. Accordingly, no representation, warranty or<br />

undertaking, express or implied, is or will be made and no responsibility or liability is or will be accepted by<br />

the Trustee, the Dealers or the Arranger as to the accuracy or completeness of the information contained in<br />

this Issuer Addendum or in any other information provided by the Issuer in connection with the <strong>Programme</strong><br />

or the <strong>Note</strong>s or their distribution and none of the Trustee, the Dealer or the Arranger accepts any liability<br />

therefor. The statements made in this paragraph are made without prejudice to the responsibility of the<br />

Issuer under the <strong>Programme</strong>.<br />

This Issuer Addendum does not constitute, and may not be used for the purposes of, an offer or solicitation<br />

by anyone in any jurisdiction in which such offer or solicitation is not authorised or to any person to whom it<br />

is unlawful to make such offer or solicitation, and no action is being taken which would permit an offering of<br />

the <strong>Note</strong>s or the distribution of the Base Prospectus or any Series Prospectus in any jurisdiction where action<br />

for such purpose is required.<br />

The only assets of the Issuer available to meet the claims of the <strong>Note</strong>holders of any Series will be the<br />

assets secured in respect of that Series.<br />

Arranger<br />

Bear, Stearns International <strong>Limited</strong><br />

Dealers<br />

Bear, Stearns International <strong>Limited</strong> Bear, Stearns & Co. Inc.<br />

Bear Stearns Bank plc<br />

The date of this Issuer Addendum is 22 November 2007<br />

2


Neither this Issuer Addendum nor other information supplied in connection with the <strong>Programme</strong> or the <strong>Note</strong>s<br />

(i) is intended to provide the basis of any credit or other evaluation or (ii) should be considered as a<br />

recommendation or as constituting an invitation or offer by any Issuer, the Trustee or any of the Dealers that<br />

any recipient of this Issuer Addendum or other information supplied in connection with the <strong>Programme</strong> or<br />

any <strong>Note</strong>s should purchase any <strong>Note</strong>s. Each investor contemplating purchasing any <strong>Note</strong>s should make its<br />

own independent investigation of the financial condition and affairs, and its own appraisal of the<br />

creditworthiness, of the Issuer, the relevant Swap Counterparty (if any), the relevant Issuer Credit Enhancer<br />

(if any), the relevant Credit Support Provider (if any), the relevant Swap Guarantor (if any), the Reference<br />

Entit(y/ies) (if any), the obligor under the relevant Charged Assets and the past and possible future<br />

performance of any relevant index or security (see the section entitled "Risk Factors" on page 6 for a<br />

discussion of certain factors to be considered in connection with an investment in the <strong>Note</strong>s). Neither this<br />

Issuer Addendum nor any other information supplied in connection with the <strong>Programme</strong> or any <strong>Note</strong>s<br />

constitutes an offer or invitation by or on behalf of any Issuer or any of the Dealers to any person to<br />

subscribe for or to purchase any <strong>Note</strong>s.<br />

The delivery of the Base Prospectus or any Series Prospectus or the offering, sale or delivery of any <strong>Note</strong>s<br />

shall not at any time or in any circumstances imply that the information contained herein or therein<br />

concerning the Issuer is correct at any time subsequent to the date hereof or thereof (as the case may be) or<br />

that any other information supplied in connection with the <strong>Programme</strong> is correct as of any time subsequent to<br />

the date indicated in the document containing the same. The Trustee, the Arranger and the Dealers expressly<br />

do not undertake to review the financial condition or affairs of the Issuer, any Swap Counterparty, any Issuer<br />

Credit Enhancer, any Credit Support Provider, any Swap Guarantor, any Reference Entity or any obligor<br />

under any Charged Assets during the life of the <strong>Programme</strong>. Investors should review, inter alia, the most<br />

recent financial statements, (if any), of the Issuer, the relevant Swap Counterparty (if any), the relevant<br />

Issuer Credit Enhancer (if any), the relevant Credit Support Provider (if any), the relevant Swap Guarantor<br />

(if any), the Reference Entity(ies) (if any) and any obligor under the relevant Charged Assets when deciding<br />

whether or not to purchase any <strong>Note</strong>s.<br />

The Base Prospectus or any Series Prospectus does not constitute an offer to sell or the solicitation of an<br />

offer to buy any <strong>Note</strong>s in any jurisdiction to any person to whom it is unlawful to make the offer or<br />

solicitation in such jurisdiction. The distribution of the Base Prospectus or any Series Prospectus and the<br />

offer or sale of <strong>Note</strong>s may be restricted by law in certain jurisdictions. The Issuer, the Trustee, the Arranger<br />

and the Dealers do not and will not represent that the Base Prospectus or any Series Prospectus may be<br />

lawfully distributed, or that the <strong>Note</strong>s may be lawfully offered, in compliance with any applicable<br />

registration or other requirements in any such jurisdiction, or pursuant to an exemption available thereunder,<br />

or assume any responsibility for facilitating any such distribution or offering. In particular, no action has<br />

been or will be taken by the Issuer, the Trustee, the Arranger or the Dealers which would permit a public<br />

offering of the <strong>Note</strong>s or distribution of the Base Prospectus or any Series Prospectus in any jurisdiction<br />

where action for that purpose is required. Accordingly, the <strong>Note</strong>s may not be offered or sold, directly or<br />

indirectly, and neither the Base Prospectus or any Series Prospectus nor any advertisement or other offering<br />

material may be distributed or published in any jurisdiction, except under circumstances that will result in<br />

compliance with any applicable laws and regulations. Persons into whose possession the Base Prospectus or<br />

any Series Prospectus or <strong>Note</strong>s come must inform themselves about, and observe, any such restrictions. In<br />

particular, there are restrictions on the distribution of the Base Prospectus or any Series Prospectus and the<br />

offer or sale of <strong>Note</strong>s in the United States (or to or for the account or benefit of U.S. persons), the European<br />

Economic Area (including the United Kingdom, the Grand Duchy of Luxembourg, Germany, the Republic<br />

of Italy, Spain, The Netherlands, Belgium and France), Japan and the Cayman Islands (see the section<br />

entitled "Subscription and Sale and Transfer Restrictions" in the Base Prospectus).<br />

Circular 230 Notice<br />

To ensure compliance with U.S. Treasury Department regulations, we advise you that any tax discussion<br />

herein was not written and is not intended to be used and cannot be used by any taxpayer for purposes of<br />

avoiding U.S. federal income tax penalties that may be imposed on the taxpayer. Any such tax discussion<br />

was written to support the promotion or marketing of the <strong>Note</strong>s to be issued pursuant to the Base Prospectus.<br />

3


Each taxpayer should seek advice based on the taxpayer's particular circumstances from an independent tax<br />

advisor.<br />

Notwithstanding any provision herein and the otherwise confidential nature of this Issuer Addendum and its<br />

contents, and effective from the date of commencement of discussions concerning the transaction described<br />

or contemplated hereby, each party to such transactions (and each employee, representative, or other agent of<br />

such party) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax<br />

structure of the transactions and all materials of any kind (including opinions or other tax analyses) that are<br />

provided to it relating to such tax treatment and tax structure, except to the extent that any such disclosure<br />

could reasonably be expected to cause the transactions not to be in compliance with securities laws. In<br />

addition, no person may disclose the name of or identifying information with respect to any party identified<br />

herein or other non-public business or financial information that is unrelated to the tax treatment or tax<br />

structure of the transactions without the prior consent of the Issuer. For the purposes of this paragraph, the<br />

tax treatment of the transactions is the purported or claimed U.S. federal income tax treatment of the<br />

transactions, and the tax structure of the transactions is any fact that may be relevant to understanding the<br />

purported or claimed U.S. federal income tax treatment of the transactions.<br />

4


Table of Contents<br />

Risk Factors .........................................................................................................................................6<br />

Documents Incorporated by Reference..................................................................................................13<br />

Ashwell Rated S.A. ..............................................................................................................................14<br />

General Information .............................................................................................................................17<br />

5


RISK FACTORS<br />

The purchase of <strong>Note</strong>s may involve substantial risks and is suitable only for sophisticated investors who have<br />

the knowledge and experience in financial and business matters necessary to enable them to evaluate the<br />

risks and the merits of an investment in the <strong>Note</strong>s.<br />

The Issuer believes that the following factors may be relevant to it and its industry. All of these factors are<br />

contingencies which may or may not occur and the Issuer is not in a position to express a view on the<br />

likelihood of any such contingency occurring.<br />

The Issuer believes that the factors described below represent the principal risks inherent in investing in<br />

<strong>Note</strong>s issued under the <strong>Programme</strong>, but the inability of the Issuer to pay interest, principal or other amounts<br />

on or in connection with any <strong>Note</strong>s may occur for other reasons and such Issuer does not represent that the<br />

statements below regarding the risks of holding any <strong>Note</strong>s are exhaustive. Prospective investors should also<br />

read the detailed information set out in the Base Prospectus and the relevant Series Prospectus and, in the<br />

light of their own financial circumstances and investment objectives, reach their own views prior to making<br />

any investment decision.<br />

Securitisation Act 2004 and Compartments<br />

The Issuer is established as a société de titrisation within the meaning of the Luxembourg act dated 22<br />

March 2004 on securitisation (the Securitisation Act 2004). The Issuer is not a regulated undertaking and is<br />

not subject to the supervision of the Luxembourg financial sector and stock exchange regulator, the CSSF.<br />

Pursuant to the Securitisation Act 2004, claims against the Issuer by holders of each Series of <strong>Note</strong>s will be<br />

limited to the net assets of the relevant Series included in the relevant compartment within the meaning of<br />

article 62 of the Securitisation Act 2004 (the Compartment). The board of directors of the Issuer (the<br />

Board) may establish one or more Compartments each of which is a separate and distinct part of the Issuer’s<br />

estate (patrimoine) and which may be distinguished by the nature of acquired risks or assets, the Conditions<br />

of the <strong>Note</strong>s issued in relation to the Compartment, the reference currency or other distinguishing<br />

characteristics. The Conditions relating to the <strong>Note</strong>s issued in respect of, and the specific objects of, each<br />

Compartment shall be determined by the Board. Each holder of <strong>Note</strong>s issued by the Issuer shall be deemed<br />

to fully adhere to, and be bound by, the Conditions and the articles of incorporation of the Issuer (the<br />

Articles).<br />

Subject to any particular rights or limitations for the time being attached to any <strong>Note</strong>s, as may be specified in<br />

the Articles or upon which such <strong>Note</strong>s may be issued including, without limitation, the Conditions, if a<br />

Compartment is liquidated its assets shall be applied in the order set out in the Conditions.<br />

As set out above, each Compartment corresponds to a separate and distinct part of the Issuer's estate<br />

(patrimoine). The rights of holders of <strong>Note</strong>s issued in respect of a Compartment and the rights of creditors<br />

are limited to the assets of that Compartment, where these rights relate to that Compartment or have arisen at<br />

the occasion of the constitution, the operation or the liquidation of the relevant Compartment. The assets of a<br />

Compartment are exclusively available to satisfy the rights of holders of <strong>Note</strong>s issued in relation to that<br />

Compartment and the rights of creditors whose claims have arisen at the occasion of the constitution, the<br />

operation or the liquidation of that Compartment.<br />

In the relationship between the holders of <strong>Note</strong>s of different Series, each Compartment is deemed to be a<br />

separate entity.<br />

Fees, expenses and other liabilities incurred on behalf of the Issuer as a whole shall, unless otherwise<br />

determined by the Board, be general liabilities of the Issuer and shall not be payable out of the assets of any<br />

Compartment. The Board shall endeavour, to the extent possible (although there is no guarantee that the<br />

Board will be able to achieve this), that creditors of such liabilities waive recourse to the assets of any<br />

Compartment.<br />

6


The Board shall establish and maintain separate accounting records for each of the Compartments of the<br />

Issuer for the purposes of ascertaining the rights of holders of <strong>Note</strong>s issued in respect of each Compartment<br />

for the purposes of the Articles and the Conditions of the <strong>Note</strong>s, such accounting records being conclusive<br />

evidence of such rights in the absence of proven manifest error.<br />

The assets of each Compartment (the Series Assets) may include the proceeds of the issue of the <strong>Note</strong>s of<br />

the relevant Series of <strong>Note</strong>s, the relevant Charged Assets and Mortgaged Property and any Charging<br />

Document or Charged Agreement. The fees, costs and expenses in relation to the <strong>Note</strong>s of each Series are<br />

allocated to the Compartment relating to the relevant Series in accordance with the Conditions and the<br />

Articles. <strong>Note</strong>holders of a Series will have recourse only to the Series Assets relating to the relevant Series.<br />

The rights of all holders of a Series will be restricted to the Series Assets for such Series regardless of how<br />

many Tranches of <strong>Note</strong>s or Classes of <strong>Note</strong>s are comprised within such Series.<br />

Pursuant to the Securitisation Act 2004, the proceeds of the Series Assets for each Series are available for<br />

distribution only to the specified <strong>Note</strong>holders and the creditors (including, but not limited to, the Trustee and<br />

any Swap Counterparty) relating to such Series (each such party, a Series Party). A creditor of the Issuer<br />

may have claims against the Issuer in respect of more than one Series, in which case the claims in respect of<br />

each Series will be limited to the Series Assets relating to such Series only.<br />

The right of <strong>Note</strong>holders of any Series issued in respect of, and allocated to, each Compartment to participate<br />

in the assets of the Issuer is limited to the Series Assets relating to such Series. If the payments received by<br />

the Issuer in respect of the Series Assets are not sufficient to make all payments due in respect of the <strong>Note</strong>s,<br />

the obligations of the Issuer in respect of the relevant Series of <strong>Note</strong>s will be limited to the Series Assets of<br />

the Compartment in respect of that Series, as specified in the Conditions and the relevant Series Prospectus<br />

(if any). The Issuer will not be obliged to make any further payment for any Series of <strong>Note</strong>s in excess of the<br />

amounts received upon the realisation of the Series Assets for the relevant Compartment. Following the<br />

application of the proceeds of realisation of the relevant Series Assets in accordance with the Conditions, the<br />

claims of the <strong>Note</strong>holders, the hedging counterparties (if any) and any other Series Parties for any shortfall<br />

shall be extinguished and the <strong>Note</strong>holders, the hedging counterparties (if any) and the other Series Parties<br />

(and any person acting on behalf of any of them) may not take any further action to recover such shortfall.<br />

In particular, no such party will be able to petition for the winding-up of the Issuer. Failure to make payment<br />

in respect of any shortfall shall in no circumstances constitute an Event of Default under the Conditions. Any<br />

shortfall shall be borne by the <strong>Note</strong>holders, each hedging counterparty (if any) and any other Series Party of<br />

the relevant Series in respect of which the <strong>Note</strong>s have been issued according to the priorities specified in the<br />

Conditions of the <strong>Note</strong>s.<br />

To give effect to the provisions of the Securitisation Act 2004 under which the Series Assets of a<br />

Compartment are available only for the Series Parties for the relevant Series relating to that Compartment,<br />

the Issuer will seek to contract with parties on a "limited recourse" basis such that claims against the Issuer<br />

would be restricted to the Series Assets of the Compartment for the relevant Series.<br />

No party will be able to attach or otherwise seize the assets of the Issuer allocated to the relevant<br />

Compartment or to other compartments of the Issuer or other assets of the Issuer.<br />

However, there is no guarantee that the Issuer will be able to contract on a limited recourse basis with respect<br />

to all agreements that the Issuer may from time to time enter into in relation to any particular Tranche, Class<br />

or Series and there may be creditors whose claims are preferred by law. In such circumstances, the Series<br />

Assets relating to one or more Compartments may be subject to claims by creditors other than the relevant<br />

Series Parties for the relevant Series resulting in a shortfall in the amounts available to meet the claims of the<br />

relevant Series Parties.<br />

7


Allocation of Shortfalls Among Classes or Tranches of a Series<br />

The Issuer expects from time to time to make issues of <strong>Note</strong>s in different Series, each comprising one or<br />

more Classes or Tranches. The assets secured for each Class or Tranche within a Series will not be held in a<br />

separate Compartment (and therefore will not be deemed to be separate from one another).<br />

Each Class or Tranche of a Series will represent a separate class or tranche of <strong>Note</strong>s and each Series will<br />

have Series Assets relating to that Series. The relevant Series Assets will be available to meet all the<br />

liabilities of the relevant Series, regardless of the different amounts stated to be payable on the separate<br />

Tranches (as set out in the relevant Series Prospectus).<br />

In practice, cross liability between Classes or Tranches is only likely to arise where the aggregate amounts<br />

payable in respect of any Class or Tranche (expected to be the redemption amount and any interest which<br />

may be payable in accordance with the Conditions applicable to that Class or Tranche) exceed the relevant<br />

Series Assets notionally allocated to that Class or Tranche (that is, those amounts (if any) received by the<br />

Issuer under the relevant Charged Assets and Mortgaged Property and Charging Document(s) and Charged<br />

Agreement(s) and any other assets comprising the relevant Series Assets after payment of all fees, costs,<br />

expenses and other liabilities which are to be borne by the relevant Series Assets and which rank before the<br />

holders of the relevant <strong>Note</strong>s) that are intended to fund payments in respect of such Class or Tranche or are<br />

otherwise attributable to that Class or Tranche. In these circumstances, the remaining Series Assets<br />

notionally allocated to any other Class or Tranche of the same Series may be available to meet such<br />

payments and may accordingly not be available to meet any amounts that otherwise would have been<br />

payable on such other Class or Tranche.<br />

Allocation of Liabilities among all <strong>Note</strong>holders<br />

Any liability which is not a Series-specific liability (that is, any liability that does not relate to the<br />

Compartment in respect of which the Series is issued) which is not otherwise funded will be apportioned<br />

between the Series Assets of all the <strong>Note</strong>s pro rata to the amounts owing on such <strong>Note</strong>s. The apportionment<br />

of such liability will reduce the return that would otherwise have been payable on such <strong>Note</strong>s. The Issuer<br />

will seek to contract with all counterparties on a limited recourse basis such that claims in respect of any<br />

liability which is not Series-specific may not be made in respect of the Series Assets of any Compartment.<br />

However, any creditor who has not contracted with the Issuer on a limited recourse basis (or any creditor<br />

with claims preferred by law, as the case may be) may make a claim against the Series Assets of a<br />

Compartment and such claim could affect the amount of Series Assets available to meet the obligations of<br />

the Issuer to the relevant <strong>Note</strong>holders and the other Series Parties.<br />

Consequences of Winding-up Proceedings<br />

If the Issuer fails, for any reason, to meet its obligations or liabilities (for instance, if the Issuer is unable to<br />

pay its debts and may obtain no further credit), a creditor may be entitled to make an application for the<br />

commencement of insolvency proceedings against the Issuer. The commencement of such proceedings may<br />

involve certain conditions, entitle creditors (including hedging counterparties) to terminate contracts with the<br />

Issuer (including hedging agreements) and claim damages for any loss arising from such early termination.<br />

The commencement of such proceedings may result in the Issuer's assets (including the Series Assets of all<br />

the Series) being realised and applied to pay the fees and costs of the liquidator, debts preferred by law and<br />

debts payable in insolvency, before any surplus is distributed to the <strong>Note</strong>holders. In the event of proceedings<br />

being commenced, the Issuer may not be able to pay the full redemption amount or any amount of interest,<br />

and any other or alternative amounts anticipated by the Conditions in respect of any Class or Tranche or<br />

Series of <strong>Note</strong>s. The Issuer will seek to contract only with parties who agree not to make application for the<br />

winding-up, liquidation or bankruptcy of the Issuer or any similar insolvency related proceedings.<br />

<strong>Limited</strong> recourse<br />

(A) The rights of <strong>Note</strong>holders of any Series issued in respect of, and allocated to, each Compartment to<br />

participate in the assets of the Issuer is limited to the Series Assets relating to each Series. All<br />

8


payments to be made by the Issuer in respect of the <strong>Note</strong>s, Receipts and Coupons of each Series and<br />

the relative Swap Agreement (if any) will be made only from and to the extent of the sums received<br />

or recovered from time to time by or on behalf of the Issuer or the Trustee in respect of (i) the<br />

relative Charged Assets and the relative Credit Support Document(s) and (ii) in the case of the<br />

<strong>Note</strong>s, Receipts and Coupons of each Series, the other Mortgaged Property (as defined in Condition<br />

3(a) (Security - Security)) in respect of such Series (applied, if applicable, in accordance with the<br />

ranking of the Classes within such Series);<br />

(B) To the extent that such sums are less than the amount which the holders of the <strong>Note</strong>s, Receipts and<br />

Coupons and such Swap Counterparty (if any) may have expected to receive if paragraph (A) above<br />

did not apply (the difference being referred to herein as a "shortfall"), such shortfall will be borne by<br />

such holders and by such Swap Counterparty (if any) in accordance with the "Terms and Conditions<br />

of the <strong>Note</strong>s" set out in the Base Prospectus and, where applicable, the Security Ranking Basis<br />

specified in the applicable Series Prospectus and, if applicable, the relevant ranking of the Classes<br />

within such Series; and<br />

(C) Each holder of <strong>Note</strong>s, Receipts or Coupons, by subscribing for or purchasing such <strong>Note</strong>s, Receipts or<br />

Coupons and each Swap Counterparty (if any), will be deemed to accept and acknowledge that it is<br />

fully aware that:<br />

(i) the holders of the <strong>Note</strong>s, Receipts and Coupons and the Swap Counterparty (if any) shall<br />

look solely to the sums referred to in paragraph (A), as applied in accordance with paragraph<br />

(B) above, (the Relevant Sums) for payments to be made by the Issuer in respect of the<br />

<strong>Note</strong>s, Receipts and Coupons and the Swap Agreement (if any) and the other assets (if any)<br />

of the Issuer including, in particular, assets securing other Series of <strong>Note</strong>s will not be<br />

available to make payments of any shortfall;<br />

(ii) the obligations of the Issuer to make payments in respect of the <strong>Note</strong>s, Receipts and<br />

Coupons and the Swap Agreement(s) (if any) will be limited to the Relevant Sums and the<br />

holders of the <strong>Note</strong>s, Receipts and Coupons and the Swap Counterparty (if any) shall have<br />

no further recourse to the Issuer in respect of the <strong>Note</strong>s, Receipts, Coupons and the Swap<br />

Agreement (if any), respectively;<br />

(iii) without prejudice to the foregoing, any right of the holders of the <strong>Note</strong>s, Receipts and<br />

Coupons and any Swap Counterparty to claim payment of any amount exceeding the<br />

Relevant Sums shall be automatically extinguished;<br />

(iv) the holders of the <strong>Note</strong>s, Receipts and Coupons and any Swap Counterparty shall not be able<br />

to petition for the winding-up, liquidation or bankruptcy of the Issuer or any similar<br />

insolvency related proceedings as a consequence of any such shortfall;<br />

(v) the holders of the <strong>Note</strong>s, Receipts and Coupons and any Swap Counterparty shall not be able<br />

to attach or otherwise seize the assets of the Issuer allocated to the relevant Compartment of<br />

the Issuer or other assets of the Issuer; and<br />

(vi) the obligations of the Issuer are solely the corporate obligations of the Issuer and no recourse<br />

for the payment of any obligation of the Issuer shall be had against any director, employee,<br />

officer, stockholder, affiliate, incorporator, manager or member of the Issuer.<br />

Such limitation shall be without prejudice to any claims against the relevant Issuer Credit Enhancer (if any).<br />

For the avoidance of doubt, <strong>Note</strong>s are not, and do not represent or convey any interest in a direct or indirect<br />

obligation of the obligors of the Charged Assets or of any Reference Entity or any Reference Obligations,<br />

nor do they confer on the <strong>Note</strong>holder any right (whether in respect of voting, dividend or other distributions<br />

in respect of the Charged Assets or any Reference Obligations) which the holder of any of the Charged<br />

Assets or Reference Obligations may have. The Issuer is not an agent of the <strong>Note</strong>holder for any purpose.<br />

9


The different Classes of <strong>Note</strong>s<br />

Unless otherwise specified in the applicable Series Prospectus, upon the enforcement of the security for<br />

<strong>Note</strong>s of a Series comprising more than one Class, payment of amounts due to the holders of a Class of<br />

<strong>Note</strong>s ranking senior to one or more junior ranking Class or Classes of <strong>Note</strong>s shall be made before payment<br />

is made to the next most senior ranking Class of <strong>Note</strong>s.<br />

The Trustee will generally be required to have regard to the separate interests of the holders of each Class.<br />

However, in certain circumstances the Trustee shall be required not to have regard to the interests of the<br />

holders of a Class of <strong>Note</strong>s ranking junior to one or more senior ranking Class of <strong>Note</strong>s to the extent any of<br />

such senior Class or Classes of <strong>Note</strong>s remain outstanding.<br />

No secondary market<br />

In the case of unlisted <strong>Note</strong>s in particular, no secondary market is expected to develop in respect of the <strong>Note</strong>s<br />

and, in the unlikely event that a secondary market in the <strong>Note</strong>s does develop, there can be no assurance that it<br />

will continue. Accordingly, the purchase of <strong>Note</strong>s is suitable only for investors who can bear the risks<br />

associated with a lack of liquidity in the <strong>Note</strong>s and the financial and other risks associated with an<br />

investment in the <strong>Note</strong>s.<br />

Taxation<br />

Each <strong>Note</strong>holder will assume and be solely responsible for any and all taxes of any jurisdiction or<br />

governmental or regulatory authority, including, without limitation, any state or local taxes or other like<br />

assessment or charges that may be applicable to any payment to it in respect of the <strong>Note</strong>s. The Issuer will<br />

not pay any additional amounts to <strong>Note</strong>holders to reimburse them for any tax, assessment or charge required<br />

to be withheld or deducted from payments in respect of the <strong>Note</strong>s by the Issuer or any Paying Agents.<br />

Passive Foreign Investment Company Status<br />

As the Issuer expects to be classified as a passive foreign investment company (PFIC) for U.S. federal<br />

income tax purposes, United States persons that hold <strong>Note</strong>s that are treated as equity for U.S. federal<br />

income tax purposes may suffer adverse tax consequences, including higher tax rates and potentially<br />

punitive interest charges on distributions on, and the proceeds of a sale of, the <strong>Note</strong>s.<br />

In the event that any <strong>Note</strong>s are treated as equity for U.S. federal income tax purposes, for the current year or<br />

future taxable years, United States persons that hold or beneficially own such <strong>Note</strong>s would be subject to<br />

adverse U.S. tax consequences. A PFIC determination must be made annually at the close of each taxable<br />

year and is based on, among other things, the composition of the Issuer's income and the value of the Issuer's<br />

passive assets, such as cash and cash equivalents (including cash raised in the offering), as well as the level<br />

of the Issuer's active assets in that year. See "Taxation – United States Federal Income Taxation – Tax<br />

Considerations if <strong>Note</strong>s are Characterised as Equity for U.S. Federal Income Tax Purposes - Passive<br />

Foreign Investment Company Considerations" in the Base Prospectus.<br />

Trading in the clearing systems<br />

In relation to any issue of <strong>Note</strong>s which have a minimum denomination and are tradable in the clearing<br />

systems in amounts above such minimum denomination but in multiples that are smaller than the minimum<br />

denomination, should definitive <strong>Note</strong>s be required to be issued, a holder who does not have an integral<br />

multiple of the minimum denomination (or its equivalent) in his account with the relevant clearing system at<br />

the relevant time may not receive all of his entitlement in the form of definitive <strong>Note</strong>s unless and until such<br />

time as his holding becomes an integral multiple of the minimum denomination.<br />

10


Investment Company Act<br />

Sales or transfers of <strong>Note</strong>s that would cause the Issuer to be required to register as an "investment company"<br />

under the Investment Company Act will be void and will not be honoured by the Issuer. If, at any time, a<br />

<strong>Note</strong> is held by or on behalf of a U.S. person (as defined in Regulation S) who is not an Eligible Investor at<br />

the time it purchases such <strong>Note</strong>, the Issuer may, in its discretion, redeem the <strong>Note</strong>s of any such holder who<br />

holds any <strong>Note</strong> in violation of the applicable transfer restrictions or compel any such holder to transfer the<br />

<strong>Note</strong>s to an Eligible Investor, in each case, at the expense and risk of such holder.<br />

Credit Risk<br />

A prospective purchaser of the <strong>Note</strong>s should have such knowledge and experience in financial and business<br />

matters and expertise in assessing credit risk that it is capable of evaluating the merits, risks and suitability of<br />

investing in the <strong>Note</strong>s including any credit risk associated with the Issuer, Swap Counterparty (if any), Swap<br />

Guarantor (if any), Credit Support Provider (if any) and Issuer Credit Enhancer (if any).<br />

Provision of information<br />

None of the Issuer, the Trustee, the Dealers or any affiliate makes any representation as to the credit quality<br />

of any Swap Counterparty, Swap Guarantor, Issuer Credit Enhancer, Credit Support Provider, Reference<br />

Entity or obligor of a Charged Asset or Reference Obligation. Any of such persons may have acquired, or<br />

during the term of the <strong>Note</strong>s may acquire, non-public information with respect to any Swap Counterparty,<br />

Swap Guarantor, Issuer Credit Enhancer, Credit Support Provider, Reference Entity or obligor of a Charged<br />

Asset or Reference Obligation. None of such persons is under any obligation to make such information<br />

directly available to <strong>Note</strong>holders. None of such persons is under any obligation to make available any<br />

information relating to, or keep under review on the <strong>Note</strong>holders' behalf, the business, financial conditions,<br />

prospects, creditworthiness or status of affairs of the obligors of the Charged Assets or any Reference<br />

Obligations or any Reference Entity, or conduct any investigation or due diligence into the obligors of the<br />

Charged Assets or any Reference Obligations or any Reference Entity.<br />

Business relationships<br />

The Issuer, the Dealers or any affiliate may have existing or future business relationships with any Swap<br />

Counterparty, Swap Guarantor, Issuer Credit Enhancer, Credit Support Provider, Reference Entity or obligor<br />

of a Charged Asset or Reference Obligation (including, but not limited to, lending, depository, risk<br />

management, advisory and banking relationships), and will pursue actions and take steps that they deem or it<br />

deems necessary or appropriate to protect their or its interests arising therefrom without regard to the<br />

consequences for a <strong>Note</strong>holder. In addition, the Issuer, the Dealers or any affiliate may make a market or<br />

hold positions in respect of any of the Charged Assets, Reference Entities or Reference Obligations relating<br />

to any particular transaction.<br />

Payments to third parties by Dealers<br />

In the context of an issuance of <strong>Note</strong>s, a Dealer may make payments of introduction, finding or structuring<br />

fees to third parties who may or may not be connected with the investor to whom the relevant Dealer initially<br />

sells the <strong>Note</strong>s.<br />

Legality of purchase<br />

None of the Issuer, the Trustee, the Dealers or any affiliate has or assumes responsibility for the lawfulness<br />

of the acquisition of the <strong>Note</strong>s by a prospective purchaser of the <strong>Note</strong>s, whether under the laws of the<br />

jurisdiction of its incorporation or the jurisdiction in which it operates (if different), or for compliance by that<br />

prospective purchaser with any law, regulation or regulatory policy applicable to it. However,<br />

notwithstanding the lawfulness of any acquisition of the <strong>Note</strong>s, where a <strong>Note</strong> is held by or on behalf of a<br />

U.S. person (as defined in Regulation S) who is not an Eligible Investor at the time it purchases such <strong>Note</strong>,<br />

the Issuer may, in its discretion, redeem the <strong>Note</strong>s of any such holder who holds any <strong>Note</strong> in violation of the<br />

11


application transfer restrictions or compel any such holder to transfer the <strong>Note</strong>s to an Eligible Investor, in<br />

each case, at the expense and risk of such holder.<br />

Independent review and advice<br />

Each prospective purchaser of <strong>Note</strong>s must determine, based on its own independent review and such<br />

professional advice as it deems appropriate under the circumstances, that its acquisition of the <strong>Note</strong>s (i) is<br />

fully consistent with its (or if it is acquiring the <strong>Note</strong>s in a fiduciary capacity, the beneficiary's) financial<br />

needs, objectives and condition, (ii) complies and is fully consistent with all investment policies, guidelines<br />

and restrictions applicable to it (whether acquiring the <strong>Note</strong>s as principal or in a fiduciary capacity) and (iii)<br />

is a fit, proper and suitable investment for it (or if it is acquiring the <strong>Note</strong>s in a fiduciary capacity, for the<br />

beneficiary), notwithstanding the clear and substantial risks inherent in investing in or holding the <strong>Note</strong>s.<br />

No reliance<br />

A prospective purchaser may not rely on the Issuer, the Trustee, the Dealers or any affiliate in connection<br />

with its determination as to the legality of its acquisition of the <strong>Note</strong>s or as to the other matters referred to<br />

above.<br />

Enforcement of legal liabilities<br />

The Issuer is incorporated under the laws of the Grand Duchy of Luxembourg. All of the directors of the<br />

Issuer under this <strong>Programme</strong> reside, and substantially all of the assets of the Issuer are, located outside the<br />

United States. It may not be possible to enforce, in original actions in Luxembourg courts, liabilities<br />

predicated solely on the U.S. federal securities laws.<br />

12


Documents Incorporated by Reference<br />

The following documents which have been previously published and have been filed with the Irish Stock<br />

Exchange shall be deemed to be incorporated in, and form part of, this Issuer Addendum:<br />

· the annual financial statements of Ashwell Rated for the financial year ended 10 October 2005;<br />

· the annual financial statements of Ashwell Rated for the financial year ended 10 October 2006; and<br />

· pages 1 to 194 (inclusive) of the Base Prospectus dated 22 November 2007 in relation to the <strong>Programme</strong>.<br />

The information on pages 195 to 216 (inclusive) of the Base Prospectus dated 22 November 2007 in relation<br />

to the <strong>Programme</strong> is not relevant to the investor.<br />

13


General<br />

Ashwell Rated S.A.<br />

Ashwell Rated S.A. (Ashwell Rated) is a securitisation company (société de titrisation) incorporated under<br />

the laws of the Grand Duchy of Luxembourg on 17 May 2005 as a public limited liability company (société<br />

anonyme) with an unlimited duration. Ashwell Rated is a special purpose entity incorporated, amongst other<br />

things, for the purpose of issuing asset backed securities. Copies of its articles of incorporation were lodged<br />

with the Luxembourg trade and companies register on 18 May 2005. The registration number of Ashwell<br />

Rated is B.107.848. Ashwell Rated's articles of incorporation are published in the "Mémorial, Recueil des<br />

Sociétés et Associations, Luxembourg" number 947 dated 27 September 2005 on page 45436. The registered<br />

office of Ashwell Rated is Carré Bonn, 20, rue de la Poste, L-2346 Luxembourg and its telephone number is<br />

(+352) 47 23 23.<br />

Share Capital and Shareholders<br />

The shares in Ashwell Rated are held by Luxembourg Corporation Company S.A. and The Structured<br />

Charitable Trust (together, the Share Trustees) under the terms of a declaration of trust under which the<br />

Share Trustees hold the shares on trust for charitable and heritage bodies. The Issuer is directly owned and<br />

controlled by these parties. Luxembourg Corporation Company S.A. was incorporated under the laws of the<br />

Grand Duchy of Luxembourg as a public limited liability company (société anonyme). The Structured<br />

Charitable Trust is a charitable trust company incorporated under the laws of Jersey. The Share Trustees will<br />

apply any income derived by them from Ashwell Rated solely for charitable purposes.<br />

The financial year of Ashwell Rated commences on 11 October in each year and ends on 10 October of the<br />

following year. The annual general meeting of the shareholders of Ashwell Rated is held on 16 March of<br />

each year at 10.00 a.m. in Luxembourg at the registered office of Ashwell Rated.<br />

The subscribed share capital of Ashwell Rated is €31,<strong>000</strong> (thirty one thousand euro) consisting of 62 (sixty<br />

two) shares in registered form (actions nominatives) with a par value of <strong>€5</strong>00 each.<br />

Financial Statements<br />

In accordance with article 75 of the Luxembourg act dated 10 August 1915 on commercial companies, as<br />

amended (the Companies Act 1915) Ashwell Rated is obliged to publish its accounts on an annual basis<br />

within one month after their approval, by and following the requisite holding of the annual general meeting<br />

of the shareholders of Ashwell Rated. Since 17 May 2005, Ashwell Rated has not carried out any business<br />

other than entering into transactions in respect of the issue of <strong>Note</strong>s and has not entered into operations other<br />

than that of a purely administrative nature. Financial statements as of 10 October 2005 and 10 October 2006<br />

have been approved and published.<br />

Principal Activities<br />

The corporate objects of Ashwell Rated are to enter into, perform and serve as a vehicle for, any<br />

securitisation transactions as permitted under the Securitisation Act 2004. To that effect, Ashwell Rated may,<br />

inter alia, acquire or assume, directly or through another entity or vehicle, the risks relating to the holding or<br />

property of claims, receivables and/or other goods or assets (including securities of any kind), either movable<br />

or immovable, tangible or intangible, and/or risks relating to liabilities or commitments of third parties or<br />

which are inherent to all or part of the activities undertaken by third parties, by issuing securities of any kind<br />

whose value or return is linked to these risks.<br />

Ashwell Rated may assume or acquire these risks by acquiring, by any means, the claims, receivables and/or<br />

assets, by guaranteeing the liabilities or commitments or by binding itself by any other means.<br />

14


Ashwell Rated may proceed to (i) the acquisition, holding and disposal, in any form, by any means, whether<br />

directly or indirectly, of participations, rights and interests in, and obligations of, Luxembourg and foreign<br />

companies, (ii) the acquisition by purchase, subscription, or in any other manner, as well as the transfer by<br />

sale, exchange or in any other manner of stock, bonds, debentures, notes and other securities or financial<br />

instruments of any kind (including notes or parts or units issued by Luxembourg or foreign mutual funds or<br />

similar undertakings) and agreements or contracts relating thereto, and (iii) the ownership, administration,<br />

development and management of a portfolio (including, among other things, the assets referred to in (i) and<br />

(ii) above). It may further acquire, hold and dispose of interests in partnerships, limited partnerships, trusts,<br />

funds and other entities.<br />

Ashwell Rated may borrow in any form. It may issue notes, bonds, debentures, certificates, shares,<br />

beneficiary parts, warrants and any kind of debt or equity including under one or more issue programmes. It<br />

may lend funds including the proceeds of any borrowings and/or issues of securities to its subsidiaries,<br />

affiliated companies or to any other company.<br />

In accordance with, and to the extent permitted by, the Securitisation Act 2004, Ashwell Rated may also give<br />

guarantees and grant security over its assets in order to secure the obligations it has assumed for the<br />

securitisation of these assets or for the benefit of investors (including their trustee or representative, if any)<br />

and/or any issuing entity participating in a securitisation transaction of Ashwell Rated. It may not pledge,<br />

transfer, encumber or otherwise create security over some or all of its assets, unless permitted by the<br />

Securitisation Act 2004.<br />

Ashwell Rated may enter into, execute and deliver and perform any swaps, futures, forwards, derivatives,<br />

options, repurchase, stock lending and similar transactions. It may generally employ any techniques and<br />

instruments relating to investments for the purpose of their efficient management, including, but not limited<br />

to, techniques and instruments designed to protect it against credit, currency exchange, interest rate risks and<br />

other risks.<br />

The descriptions above are to be understood in their broadest sense and their enumeration is not limiting. The<br />

corporate objects shall include any transaction or agreement which is entered into by Ashwell Rated,<br />

provided it is not inconsistent with the foregoing enumerated objects.<br />

In general, Ashwell Rated may take any controlling and supervisory measures and carry out any operation or<br />

transaction which it considers necessary or useful in the accomplishment and development of its corporate<br />

objects, to the largest extent permitted under the Securitisation Act 2004.<br />

In accordance with the Securitisation Act 2004, the board of directors of Ashwell Rated is entitled to create<br />

one or more compartments (representing the assets of Ashwell Rated attributable to an issue of securities)<br />

corresponding each to a separate part of Ashwell Rated's estate.<br />

Auditors<br />

The external auditors (réviseurs d'entreprises) of Ashwell Rated are Deloitte S.A., whose registered office is<br />

at 560, rue de Neudorf, L-2220 Luxembourg, Grand Duchy of Luxembourg. Deloitte S.A. is a member of<br />

the Institut des Réviseurs d'Entreprises, which is the equivalent of the Institute of Chartered Accountants in<br />

the United Kingdom.<br />

Administrative, Management and Supervisory Bodies<br />

Ashwell Rated is managed by its board of directors composed of:<br />

1. Mr Doeke van der Molen, employee, whose business address is at Carré Bonn, 20, rue de la<br />

Poste, L-2346 Luxembourg;<br />

15


2. Ms Cândida Gillespie, employee, whose business address is at Carré Bonn, 20, rue de la<br />

Poste, L-2346 Luxembourg; and<br />

3. Mr Paul Lefering, employee, whose business address is at Carré Bonn, 20, rue de la Poste,<br />

L-2346 Luxembourg,<br />

(each a Director and together the Directors).<br />

Mr Doeke van der Molen has been appointed by the board of directors of the Issuer as<br />

chairman of the board of directors of the Issuer.<br />

No conflict exists between the duties of the Directors and the private interest of any Director.<br />

As a public limited liability company (société anonyme), Ashwell Rated must have at least three directors at<br />

all times. In the event that a director resigns but there are still three or more directors remaining in office,<br />

there is no requirement for any immediate action to be taken. A new director can then be appointed at the<br />

next general meeting (either annual or extraordinary) of the shareholders of Ashwell Rated.<br />

If a director resigns and this reduces the number of directors to less than three, a new director must be<br />

appointed so that there are at least three directors. The new director may be appointed either by: (i) an<br />

extraordinary general meeting of the shareholders of Ashwell Rated specifically convened to vote on the<br />

appointment of a new director; or (ii) the remaining directors, on a provisional basis. A director<br />

provisionally appointed by the remaining directors must have its appointment confirmed at the next general<br />

meeting (either annual or extraordinary) of the shareholders of Ashwell Rated.<br />

16


1. Authorisation<br />

GENERAL INFORMATION<br />

The Issuer has obtained all necessary consents, approvals and authorisations in connection with the<br />

issue and performance of the <strong>Note</strong>s to be issued by it. The update of the <strong>Programme</strong> was duly<br />

authorised by a resolution of the Board of Directors of Ashwell Rated dated on or about<br />

21 November 2007.<br />

2. Significant or Material Change<br />

There has been no material adverse change in the financial or trading position or prospects of<br />

Ashwell Rated since the date of its last published audited financial statements.<br />

3. Legal and Arbitration Proceedings<br />

There are no governmental, legal or arbitration proceedings (including any such proceedings which<br />

are pending or threatened of which the Issuer is aware) which may have or have had since the date of<br />

its incorporation a significant effect on the financial position or profitability of the Issuer.<br />

4. Annual Accounts<br />

In accordance with article 75 of the Companies Act 1915 Ashwell Rated is obliged to publish its<br />

accounts on an annual basis within one month after their approval, by and following the requisite<br />

holding of the annual general meeting of the shareholders.<br />

The most recently published and future annual accounts of Ashwell Rated will be available from the<br />

Specified Office of the Paying Agents in London and Ireland.<br />

5. Listing of <strong>Note</strong>s on the Irish Stock Exchange<br />

The listing of the <strong>Note</strong>s on the Irish Stock Exchange will be expressed at their nominal amount<br />

(excluding accrued interest). It is expected that each Tranche of <strong>Note</strong>s which is to be admitted to the<br />

regulated market of the Irish Stock Exchange will be admitted separately as and when issued. The<br />

approval of the Base Prospectus in respect of the <strong>Note</strong>s is expected to be granted on or before<br />

22 November 2007.<br />

6. Documents on Display<br />

For the life of the <strong>Note</strong>s copies of the following documents (in English) will, when published, be<br />

available for inspection in electronic form free of charge during usual business hours on any<br />

weekday (Saturdays, Sundays and public holidays excepted) from the registered office of the Issuer<br />

and from the specified office of each of the Paying Agents for the time being in London and Ireland:<br />

(i) the articles of incorporation of the Issuer;<br />

(ii) the most recently published audited annual financial statements of the Issuer;<br />

(iii) the Master Trust Deed (which includes the forms of the Global <strong>Note</strong>s, the Definitive <strong>Note</strong>s,<br />

the Receipts, the Coupons, the Talons and the Registered <strong>Note</strong>s), the Deed of Adherence, the<br />

Agency Agreement, the <strong>Programme</strong> Agreement, the Custodial Services Agreement and the<br />

Put Option Agreement;<br />

(iv) any supplements to the documents referred to in (iii) above which relate to a particular issue<br />

of <strong>Note</strong>s and the Charged Agreements, any Charging Documents, any Credit Support<br />

17


Documents and any <strong>Note</strong>s Guarantee relating to a particular issue of <strong>Note</strong>s (save that such<br />

documents relating to an unlisted issue of <strong>Note</strong>s will only be available for inspection by a<br />

holder of such <strong>Note</strong> and such holder must produce evidence satisfactory to the Issuer or to<br />

the relevant Paying Agent, as the case may be, as to the identity of such holder);<br />

(v) a copy of the Base Prospectus;<br />

(vi) when published, any Summary and any Series Prospectus (save that such documents relating<br />

to a <strong>Note</strong> which is neither admitted to trading on a regulated market in the European<br />

Economic Area or offered in the European Economic Area in circumstances where a<br />

prospectus is required to be published under the Prospectus Directive will only be available<br />

for inspection by a holder of such <strong>Note</strong> and such holder must produce evidence satisfactory<br />

to the Issuer or to the relevant Paying Agent, as the case may be, as to the identity of such<br />

holder); and<br />

(vii) in the case of each issue of listed <strong>Note</strong>s subscribed pursuant to a subscription agreement, the<br />

subscription agreement (or equivalent document).<br />

7. U.S. Tax Legend<br />

Each <strong>Note</strong> in bearer form which has an original maturity of more than one year and all Receipts,<br />

Coupons and Talons relating to such <strong>Note</strong>s will bear the following legend: "Any United States<br />

person who holds this obligation will be subject to limitations under the United States income tax<br />

laws, including the limitations provided in Sections 165(j) and 1287(a) of the Internal Revenue<br />

Code".<br />

8. Clearing Systems<br />

The <strong>Note</strong>s (other than those in definitive form) may be accepted for clearance through Euroclear or<br />

Clearstream, Luxembourg (which are the entities in charge of keeping the records) (in each case as<br />

specified in the applicable Series Prospectus). The appropriate Common Code and ISIN for each<br />

Tranche allocated by Euroclear or Clearstream, Luxembourg, will be specified in the applicable<br />

Series Prospectus. If the <strong>Note</strong>s are to clear through an additional or alternative clearing system the<br />

appropriate information will be specified in the applicable Series Prospectus.<br />

The address of Euroclear is Euroclear Bank S.A./N.V., 1 Boulevard du Roi Albert II, B-1210<br />

Brussels and the address of Clearstream, Luxembourg is Clearstream Banking, 42, Avenue J.F.<br />

Kennedy, L-1855 Luxembourg.<br />

9. Conditions for Determining Price<br />

The price and amount of <strong>Note</strong>s to be issued under the <strong>Programme</strong> will be determined by the Issuer<br />

and the relevant Dealer at the time of issue in accordance with prevailing market conditions.<br />

10. Restricted <strong>Note</strong>s<br />

So long as any of the <strong>Note</strong>s are "restricted <strong>Note</strong>s" within the meaning of Rule 144(a)(3) under the<br />

Securities Act, the Issuer will, unless it becomes subject to and complies with the reporting<br />

requirements of Section 13 or 15(d) of the Exchange Act or the information furnishing requirements<br />

of Rule 12g3-2(b) thereunder, provide to any holder or beneficial owner of <strong>Note</strong>s that are restricted<br />

<strong>Note</strong>s, or to any prospective purchaser of <strong>Note</strong>s that are restricted <strong>Note</strong>s designated by a holder or<br />

beneficial owner, upon the request of such holder, beneficial owner or prospective purchaser, the<br />

information required to be provided by Rule 144A(d)(4) under the Securities Act.<br />

18


11. External Auditors<br />

The external auditors (réviseur d'entreprises) of Ashwell Rated are Deloitte S.A., whose registered<br />

office is at 560, rue de Neudorf, L-2220 Luxembourg. Deloitte S.A. is a member of the Institut des<br />

Réviseurs d'Entreprises (Luxembourg institute of auditors).<br />

12. Post-Issuance Information<br />

The Issuer does not intend to provide any post-issuance information in relation to any Series of<br />

<strong>Note</strong>s or the performance of any Charged Assets or Reference Obligations.<br />

19


REGISTERED OFFICES OF<br />

THE ISSUER<br />

Ashwell Rated S.A.<br />

Carré Bonn, 20, rue de la Poste<br />

L-2346 Luxembourg<br />

PRINCIPAL PAYING AGENT, AGENT BANK AND TRANSFER AGENT<br />

Citibank, N.A.<br />

21st Floor Citigroup Centre<br />

Canada Square<br />

Canary Wharf<br />

London E14 5LB<br />

EUROPEAN REGISTRAR<br />

Citigroup Global Markets Deutschland AG & Co. KGaA<br />

German Agency and Trust Department<br />

Reuterweg 16<br />

60323 Frankfurt am Main<br />

Germany<br />

NEW YORK REGISTRAR<br />

Citibank, N.A.<br />

Citibank Agency & Trust Services<br />

14th Floor<br />

111 Wall Street<br />

New York 1<strong>000</strong>5<br />

U.S.A<br />

IRISH PAYING AGENT AND TRANSFER AGENT<br />

Citibank International plc<br />

1 North Wall Quay<br />

Dublin 1<br />

Ireland<br />

TRUSTEE<br />

Citicorp Trustee Company <strong>Limited</strong><br />

Citigroup Centre<br />

Canada Square<br />

Canary Wharf<br />

London E14 5LB<br />

20


To the Dealers and the Trustee<br />

as to English law:<br />

Simmons & Simmons<br />

One Ropemaker Street<br />

London EC2Y 9SS<br />

AUDITORS<br />

To Ashwell Rated S.A.<br />

Deloitte S.A.<br />

560, rue de Neudorf,<br />

L-2220 Luxembourg<br />

Grand Duchy of Luxembourg<br />

LEGAL ADVISERS<br />

To the Dealers as to U.S. law:<br />

Simmons & Simmons<br />

One Ropemaker Street<br />

London EC2Y 9SS<br />

IRISH LISTING AGENT<br />

A&L Listing <strong>Limited</strong><br />

International Financial Services Centre<br />

North Wall Quay<br />

Dublin 1<br />

21<br />

To the Dealers and the Trustee<br />

as to Luxembourg law:<br />

Allen & Overy Luxembourg<br />

58, rue Charles Martel<br />

L-2134 Luxembourg

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!